NCT00452452View on ClinicalTrials.gov

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children

PHASE3CompletedINTERVENTIONAL

Enrollment

355

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL

13-valent Pneumococcal Conjugate Vaccine

Trial Locations (9)

85-168

Bydgoszcz

85-316

Bydgoszcz

39-200

Dębica

31-503

Krakow

91-738

Lodz

55-120

Oborniki Salskie

61-709

Proznan

55-100

Trzebnica

21-010

Łęczna

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00452452 - Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children | Biotech Hunter | Biotech Hunter